DRUG REGULATION IN INDIA: SWOT ANALYSIS

Journal Title: International Journal of Drug Regulatory Affairs - Year 2015, Vol 3, Issue 3

Abstract

Drug regulation plays pivotal role in any country because the purpose of drug regulation is to promote and to protect public health by ensuring the safety, efficacy and quality of drugs. Drug regulation should cover all products for which medicinal claims are made and all aspects of drugs like manufacturing, import, export, distribution, dispensing, promotion, sell and supply. But unfortunately drug regulation does not meet these requirements in India as legislation omits or exempts certain areas of pharmaceutical activity from the scope of control in India. Although there are so many deficiencies, lacunae and hurdles in Indian drug regulation, there is a wider scope for drug regulation in India because government is taking positive steps to reform it. One can say India is a vast ocean of opportunities. Hence it is tried to analyse the drug regulation of India using the framework of SWOT (Strengths, Weaknesses, Opportunities, Threats). SWOT analysis aids to find out possible ways to overcome the weaknesses and threats, and to utilize the strengths and opportunities properly

Authors and Affiliations

Patel Priyanka V

Keywords

Related Articles

MEDICAL DEVICE REGULATION IN US, EUROPE, CHINA AND INDIA

Medical Device is an emerging market in last two decades since the use of medical device is escalating throughout the world. Millions of patients worldwide depend on Medical Device for the diagnosis & Management of disea...

TECHNOLOGY DVELOPMENT FOR POLYMER MODIFICATION TO ENHANCE SOLUBILITY OF POORLY SOLUBLE DRUG

Solubilization of poorly soluble drugs is a frequently encountered challenge in screening studies of new chemical entities as well as in formulation design and development. Solubility of some drugs is very less; these dr...

Comparative Study of Triglyceride Level in Ischemic Heart Disease Patients in different age groups of Patients in south east Rajasthan

Backgrounds: Elevated body triglycerides have been implicated as a risk factor of ischemic heart disease (IHD). Objectives: To study the association of serum triglyceride with ischemic heart disease and to assess the rel...

ACTD: BRIDGE BETWEEN REGULATORY REQUIREMENTS OF DEVELOPED AND DEVELOPING COUNTRIES

Regulatory Dossier contains data which when submitted to the regulatory authority, provides for the review and ultimate approval of a drug product. Once approved, an applicant may manufacture and market the drug to provi...

REGULATORY REQUIREMENTS FOR DRUG PRODUCTS REGISTRATION IN SOUTH AFRICA

The South African Pharmaceutical market is one of the emerging markets in the world and it is important to study on how to register a drug in the promising pharmaceutical market in Africa. The MCC is the regulatory body...

Download PDF file
  • EP ID EP339241
  • DOI -
  • Views 82
  • Downloads 0

How To Cite

Patel Priyanka V (2015). DRUG REGULATION IN INDIA: SWOT ANALYSIS. International Journal of Drug Regulatory Affairs, 3(3), 21-27. https://europub.co.uk/articles/-A-339241